New drug VNA-318 tested in healthy men for safety
NCT ID NCT06721091
First seen Sep 30, 2025 · Last updated May 11, 2026 · Updated 22 times
Summary
This early-phase study tested the safety and tolerability of a new drug called VNA-318 in 92 healthy male volunteers. Participants received either single or multiple doses of the drug or a placebo. The goal was to check for side effects and how the drug moves through the body, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Biotrial
Rennes, 35000, France
Conditions
Explore the condition pages connected to this study.